Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zinc oxide + thymol is a topical combination pharmaceutical product developed by Vefa İlaç, primarily marketed under the brand name Vefaderm Pudra. The formulation combines the protective and astringent properties of zinc oxide with the antiseptic and antifungal actions of thymol. Zinc oxide creates a physical barrier on the skin surface, shielding it from moisture and external irritants, which is particularly effective in treating diaper rash and prickly heat. Thymol, a phenolic compound derived from thyme oil, provides broad-spectrum antimicrobial activity to prevent secondary infections in compromised skin. While the sponsor context mentions zinc deficiency, this specific combination is traditionally utilized for localized dermatological protection and disinfection rather than systemic mineral supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zinc oxide + thymol.